Ligand Pharmaceuticals LGND
NASDAQ LGND
$312.37 +2.01 (+0.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Retained Earnings (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) recorded Retained Earnings of $583.25 million in Q2 2026, up 26.4% from $461.38 million a year earlier but down 1.9% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Retained Earnings (2010 - 2026) Analysis & Trends

At the end of FY2025, Ligand Pharmaceuticals reported Retained Earnings of $608.09 million, up 21.9% from FY2024.

  • Annual Retained Earnings has a five-year compound annual growth rate of 9.2% (FY2020 to FY2025).
  • Across earlier years, Retained Earnings came in at $498.98 million in FY2024 (-0.8%), $503.02 million in FY2023 (+11.6%), $450.86 million in FY2022 (+0.4%) and $449.09 million in FY2021 (+14.6%).
  • Quarterly Retained Earnings has ranged from $449.09 million in Q4 2021 to $608.09 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Retained Earnings has increased for four consecutive quarters, with growth averaging 7.4% over the last eight quarters.
  • Peak year-over-year performance for Retained Earnings in the last five years was growth of 30.3% in Q1 2026, against a decline of 22.5% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $594.74 million (Q1 2026), $608.09 million (Q4 2025) and $578.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 171.67 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -17.33 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 12.59 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 15.69 Bn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 583.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 583.25 Mn
Mar 31, 2026 594.74 Mn
Dec 31, 2025 608.09 Mn
Sep 30, 2025 578.22 Mn
Jun 30, 2025 461.38 Mn
Mar 31, 2025 456.53 Mn
Dec 31, 2024 498.98 Mn
Sep 30, 2024 530.07 Mn
Jun 30, 2024 537.24 Mn
Mar 31, 2024 589.16 Mn
Dec 31, 2023 503.02 Mn
Sep 30, 2023 484.83 Mn
Jun 30, 2023 495.10 Mn
Mar 31, 2023 492.81 Mn
Dec 31, 2022 450.86 Mn
Sep 30, 2022 468.35 Mn
Jun 30, 2022 467.94 Mn
Mar 31, 2022 468.84 Mn
Dec 31, 2021 449.09 Mn
Sep 30, 2021 454.51 Mn
API Access

Ligand Pharmaceuticals Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=LGND&period=max&api_key=YOUR_API_KEY